Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 39 for "lymphoma," "T-cell" OR granulomatous reaction
  1. Understanding IBD Medications and Side Effects (Crohn's & Colitis Foundation of America) - PDF  
    Ulcerative Colitis/Treatments and Therapies ... Ulcerative Colitis ... Crohn's Disease/Treatments and Therapies ... Crohn's Disease ... Crohn's & Colitis Foundation of America
  2. Research into the causes, prevention, and treatment of non-Hodgkin lymphoma is being done in many medical centers throughout the world. Learn more. ... Lymphoma/ ...
  3. ... cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in ... reaction called cytokine release syndrome (CRS). A doctor or ...
  4. ... cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in ... reaction called cytokine release syndrome (CRS). A doctor or ...
  5. ... cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in ... reaction called cytokine release syndrome (CRS). A doctor or ...
  6. ... cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in ... reaction called cytokine release syndrome (CRS). A doctor or ...
  7. ... cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in ... reaction called cytokine release syndrome (CRS). A doctor or ...
  8. ... cell lymphoma (sALCL), other certain types of peripheral T-cell lymphomas (PTCL; a type of non-Hodgkin lymphoma) and ...
  9. ... tumor in adults and children; to treat cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune ...
  10. Denileukin diftitox is used to treat cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune system that first appear as skin rashes) in people whose disease has not improved, has ...
previous · 1 · 2 · 3 · 4 · next